Vivoryon Therapeutics Stock (AMS:VVY)

NETHERLANDS |AS |EUR

Price
11.82
Change
-1.01%
Today's Range
€11.69 - €11.95
52-Week Range
€8.00 - €23.25
Market Cap
€209.04M
Volume
60.55K

About Vivoryon Therapeutics (AMS:VVY)

(AMS:VVY) Vivoryon Therapeutics N.V., a clinical stage biopharmaceutical company, engages in the research and development of therapeutic products for the treatment of Alzheimer's disease. Its pipeline products target toxic pyroglutamate-Abeta (pGlu-Abeta), which inhibits the production of pGlu-Abeta. The company's lead product candidate is PQ912, a small molecule QC inhibitor that has completed Phase IIb clinical trials for use in the treatment of Alzheimer's disease; and for the treatment of cancer. Its preclinical development product is PQ1565, a small molecule glutaminyl-peptide cyclotransferase-like inhibitor for the treatment of cancer. In addition, the company is developing a monoclonal antibody targeting pGlu-Abeta to enhance its clearance. Vivoryon Therapeutics N.V. has a research collaboration agreement with University Medical Center Schleswig-Holstein to discover and develop therapeutics in cancer immunotherapy; collaboration agreement with Nordic Bioscience for the clinical development of PQ912 for Alzheimer's disease; and research collaboration with the Fraunhofer Institute for cell therapy and immunology. Vivoryon Therapeutics N.V. was founded in 1997 and is headquartered in Halle, Germany.
Show more

VVY Stock Price

Statistics Highlights (AMS:VVY)

Shares Outstanding 22.05M Beta 1.96
Public Float 16.96M P/E Ratio -
% Short of Float - Dividend (Yield) -
Held by Insiders 26.74% Ex-Dividend Date
Held by Institutions 23.08% IPO Date -

VVY Financial Summary

|
Dec 20 Dec 19 Dec 18
Revenue €0.00 €0.00 €0.00
EBITDA €-16.34M €-7.63M €-7.67M
Net Income €-16.51M €-7.82M €-7.74M
Total Assets €29.75M €45.86M €4.05M
Total Cash €26.31M €41.52M €3.78M
Total Debt
Sep 21 Jun 21 Mar 21
Revenue
EBITDA
Net Income
Total Assets €23.04M
Total Cash €19.83M
Total Debt

VVY Stock Price History

Vivoryon Therapeutics Annual Stock Price History

Year Open Close Change
2021 €18.90 €11.82 -37.46%
2021 €9.09 €18.90 107.92%
2020 €5.35 €9.09 69.91%

Vivoryon Therapeutics Daily Stock Price History

Date Open High Low Close Change Volume
Jun 17, 2022 €7.70 €7.75 €7.11 €7.17 -14.85% 176.12K
Jun 14, 2022 €8.93 €8.93 €8.42 €8.42 -13.37% 39.15K
Jun 9, 2022 €9.60 €9.90 €9.48 €9.72 -0.72% 19.08K

(AMS:VVY) Stock Price FAQs

What is today's stock price of Vivoryon Therapeutics (AMS:VVY)?

  • The current stock price of Vivoryon Therapeutics (AMS:VVY) is €11.82.
  • Today VVY stock price opened at €11.95 after previous close of €11.94.
  • During the day, Vivoryon Therapeutics stock quote has varied from a low of €11.69 to a high of €11.95.

What is Vivoryon Therapeutics's 52-week change?

  • VVY 52-week high stock quote is €23.25, which is 96.70% above the current share price.
  • The Vivoryon Therapeutics (AMS:VVY) 52-week low stock price is €8.00, which is 32.30% below the current share price.
  • Vivoryon Therapeutics share price volatility (52-week beta) is 1.96.

Vivoryon Therapeutics (AMS:VVY) FAQ

How Much is Vivoryon therapeutics Worth?

Vivoryon therapeutics's worth today based on market capitalisation is €209.04M

How much dividend does Vivoryon therapeutics Pay?

The current annualized dividend payout for VVY stock is €0.00, the dividend yield is 0.00% and the payout ratio is 0.00%.
View More Details on Vivoryon therapeutics's "Dividend" Section

What is Vivoryon therapeutics’s Price to Earning (PE) ratio?

VVY stock also has a Price to Sales (P/S) ratio of 19.42.

What is the Vivoryon therapeutics's ticker?

Vivoryon therapeutics trades on the Euronext Amsterdam stock market in Netherlands under the ticker symbol "VVY". Vivoryon therapeutics’s stock symbol can also be displayed as "AMS:VVY".

Who are the owners of Vivoryon therapeutics?

Vivoryon therapeutics (AMS:VVY) is owned by 23.08% institutional shareholders and by 26.74% insiders. The rest is owned by the public.
Explore More Details on Vivoryon therapeutics's “Ownership” Section

Who are the key executives of Vivoryon therapeutics (VVY)?

Vivoryon therapeutics's key executive team includes the following managers:

  • Dr. Ulrich Dauer, Chairman of the Management Board & CEO (1965)
  • Dr. Michael Schaeffer, Chief Bus. Officer & Member of the Management Board (NA)
  • Mr. Florian Schmid, CFO & Member of Management Board (NA)
  • Manuela Bader, Director of Investor Relations & Communications (NA)
  • Mr. Frank T. Weber M.D., Chief Medical Officer (1960)
  • Dr. Konrad Glund, Co-Founder & Advisor (1953)
  • Dr. Hendrik Liebers, Advisor (1971)

What is Vivoryon therapeutics’s Sector & Industry Classification?

Vivoryon therapeutics (AMS:VVY) is classified under the "Healthcare" sector and under the "Biotechnology" industry.

How many employees work for Vivoryon therapeutics?

Currently the number of employees working for Vivoryon therapeutics is 18.

Where are Vivoryon therapeutics's Headquarters?

Vivoryon therapeutics (AMS:VVY) is headquartered in Germany.

What are Vivoryon therapeutics's Address and Phone Number?

Vivoryon therapeutics’s mailing address is Weinbergweg 22, Halle, Germany, 06120.
The company’s phone number is 49 345 555 9900.

What is the official website for Vivoryon therapeutics?

Vivoryon therapeutics’s official website is http://www.vivoryon.com